Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published January 1, 2001 | Published
Journal Article Open

Control of Vulval Cell Division Number in the Nematode Oscheius/Dolichorhabditis sp. CEW1

Abstract

Spatial patterning of vulval precursor cell fates is achieved through a different two-stage induction mechanism in the nematode Oscheius/Dolichorhabditis sp. CEW1 compared with Caenorhabditis elegans. We therefore performed a genetic screen for vulva mutants in Oscheius sp. CEW1. Most mutants display phenotypes unknown in C. elegans. Here we present the largest mutant category, which affects division number of the vulva precursors P(4-8).p without changing their fate. Among these mutations, some reduce the number of divisions of P4.p and P8.p specifically. Two mutants omit the second cell cycle of all vulval lineages. A large subset of mutants undergo additional rounds of vulval divisions. We also found precocious and retarded heterochronic mutants. Whereas the C. elegans vulval lineage mutants can be interpreted as overall (homeotic) changes in precursor cell fates with concomitant cell cycle changes, the mutants described in Oscheius sp. CEW1 do not affect overall precursor fate and thereby dissociate the genetic mechanisms controlling vulval cell cycle and fate. Laser ablation experiments in these mutants reveal that the two first vulval divisions in Oscheius sp. CEW1 appear to be redundantly controlled by a gonad-independent mechanism and by a gonadal signal that operates partially independently of vulval fate induction.

Additional Information

© 2001 by the Genetics Society of America. Manuscript received July 24, 2000; Accepted for publication September 18, 2000. We thank Marie Delattre and Ralf Sommer for discussions and reading of the manuscript. We are very grateful to G. Medina, M. Khairy, E. Delattre, and S. Boeuf for preparing the many worm plates that were used. P.W.S. is an Investigator with the Howard Hughes Medical Institute. M.-A.F. was supported during the course of this work by the Howard Hughes Medical Institute and the Centre National de la Recherche Scientifique. M.E.V. was supported by a Medical Research Council Career Development Award. Work in the M.-A.F. laboratory is supported by an ATIPE of Centre National de la Recherche Scientifique, the Fondation pour la Recherche Médicale and the Association pour la Recherche sur le Cancer.

Attached Files

Published - 11139501.pdf

Files

11139501.pdf
Files (453.6 kB)
Name Size Download all
md5:dd3ef34252b239f4bd22601f7a4c1499
453.6 kB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 20, 2023